Safety and Efficacy Study of NP001 in Patients With Amyotrophic Lateral Sclerosis (ALS) and Systemic Inflammation

Condition:   Amyotrophic Lateral Sclerosis
Interventions:   Drug: NP001;   Drug: Placebo
Sponsor:   Neuraltus Pharmaceuticals, Inc.
Recruiting - verified February 2017